1 |
Seow, H. A., Penketh, P. G., Belcourt, M. F., Tomasz, M., Rockwell, S. and Sartorelli, A. C. 2004. Nuclear overexpression of NAD(P)H: quinone oxidoreductase 1 in Chinese hamster ovary cells increases the cytotoxicity of mitomycin C under aerobic and hypoxic conditions. J Biol Chem 279, 31606-31612.
DOI
|
2 |
Siegel, D. and Ross, D. 2000. Immunodetection of NAD(P) H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 29, 246-253.
DOI
ScienceOn
|
3 |
Smith, D., Martin, L. and Wallin, R. 1988. Human DT-diaphorase, a potential cancer protecting enzyme. Its purification from abdominal adipose tissue. Cancer Lett 42, 103-112.
DOI
|
4 |
Song, C. W., Chae, J. J., Choi, E. K., Hwang, T. S., Kim, C., Lim, B. U. and Park, H. J. 2008. Anti-cancer effect of bio-reductive drug beta-lapachon is enhanced by activating NQO1 with heat shock. Int J Hyperthermia 24, 161-169.
DOI
|
5 |
Weller, M., Winter, S., Schmidt, C., Esser, P., Fontana, A., Dichgans, J. and Groscurth, P. 1997. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95- mediated apoptosis by camptothecin and beta-lapachone. Int J Cancer 73, 707-714.
DOI
ScienceOn
|
6 |
Thor, H., Smith, M. T., Hartzell, P., Bellomo, G., Jewell, S. A. and Orrenius, S. 1982. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J Biol Chem 257, 12419-12425.
|
7 |
Tzeng, H. P., Ho, F. M., Chao, K. F., Kuo, M. L., Lin-Shiau, S. Y. and Liu, S. H. 2003. beta-Lapachone reduces endotoxin- induced macrophage activation and lung edema and mortality. Am J Respir Crit Care Med 168, 85-91.
DOI
|
8 |
Vasiliou, V., Ross, D. and Nebert, D. W. 2006. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2, 329-335.
DOI
|
9 |
Williams, J. B., Lu, A. Y., Cameron, R. G. and Pickett, C. B. 1986. Rat liver NAD(P)H: quinone reductase. Construction of a quinone reductase cDNA clone and regulation of quinone reductase mRNA by 3-methylcholanthrene and in persistent hepatocyte nodules induced by chemical carcinogens. J Biol Chem 261, 5524-5528.
|
10 |
Winski, S. L., Koutalos, Y., Bentley, D. L. and Ross, D. 2002. Subcellular localization of NAD(P)H: quinone oxidoreductase 1 in human cancer cells. Cancer Res 62, 1420-1424.
|
11 |
Woo, H. J. and Choi, Y. H. 2005. Growth inhibition of A549 human lung carcinoma cells by beta-lapachone through induction of apoptosis and inhibition of telomerase activity. Int J Oncol 26, 1017-1023.
|
12 |
Woo, H. J., Park, K. Y., Rhu, C. H., Lee, W. H., Choi, B. T., Kim, G. Y., Park, Y. M. and Choi, Y. H. 2006. Beta-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase. J Med Food 9, 161-168.
DOI
|
13 |
Choudry, G. A., Stewart, P. A., Double, J. A., Krul, M. R., Naylor, B., Flannigan, G. M., Shah, T. K., Brown, J. E. and Phillips, R. M. 2001. A novel strategy for NQO1 (NAD (P)H: quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9. Br J Cancer 85, 1137-1146.
DOI
|
14 |
Amzel, L. M., Bryant, S. H., Prochaska, H. J. and Talalay, P. 1986. Preliminary crystallographic X-ray data for an NAD(P)H:quinone reductase from mouse liver. J Biol Chem 261, 1379.
|
15 |
Begleiter, A., El-Gabalawy, N., Lange, L., Leith, M. K., Guziec, L. J. and Guziec, F. S., Jr. 2009. A model for NAD (P)H: quinoneoxidoreductase 1 (NQO1) targeted individualized cancer chemotherapy. Drug Target Insights 4, 1-8.
|
16 |
Belinsky, M. and Jaiswal, A. K. 1993. NAD(P)H: quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues. Cancer Metastasis Rev 12, 103-117.
DOI
ScienceOn
|
17 |
D'Anneo, A., Augello, G., Santulli, A., Giuliano, M., di Fiore, R., Messina, C., Tesoriere, G. and Vento, R. 2010. Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. J Cell Physiol 222, 433-443.
DOI
|
18 |
Boveris, A., Docampo, R., Turrens, J. F. and Stoppani, A. O. 1978. Effect of beta-lapachone on superoxide anion and hydrogen peroxide production in Trypanosoma cruzi. Biochem J 175, 431-439.
|
19 |
Choi, B. T., Cheong, J. and Choi, Y. H. 2003. beta- Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kappaB in human colon cancer HCT-116 cells. Anticancer Drugs 14, 845-850.
|
20 |
Cresteil, T. and Jaiswal, A. K. 1991. High levels of expression of the NAD(P)H: quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol. 42, 1021-1027.
DOI
ScienceOn
|
21 |
Danson, S., Ward, T. H., Butler, J. and Ranson, M. 2004. DT-diaphorase: a target for new anticancer drugs. Cancer Treat Rev 30, 437-449.
DOI
ScienceOn
|
22 |
Ernster, L., Danielson, L. and Ljunggren, M. 1962. DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties. Biochim Biophys Acta 58, 171-188.
DOI
|
23 |
De Haan, L. H., Boerboom, A. M., Rietjens, I. M., van Capelle, D., De Ruijter, A. J., Jaiswal, A. K. and Aarts, J. M. 2002. A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells. Biochem Pharmacol 64, 1597-1603.
DOI
|
24 |
Gonzalez, F. J. 1988. The molecular biology of cytochrome P450s. Pharmacol Rev 40, 243-288.
|
25 |
Don, M. J., Chang, Y. H., Chen, K. K., Ho, L. K. and Chau, Y. P. 2001. Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the beta-lapachone-induced apoptosis of human prostate cancer cells. Mol Pharmacol 59, 784-794.
|
26 |
Dubin, M., Fernandez Villamil, S. H. and Stoppani, A. O. 2001. Cytotoxicity of beta-lapachone, an naphthoquinone with possible therapeutic use. Medicina (B Aires) 61, 343-350.
|
27 |
Ernster, L. and Navazio, F. 1958. Soluble diaphorase in animal tissue. Acta Chem Scand 12, 595-602.
DOI
|
28 |
Höjeberg, B., Blomberg, K., Stenberg, S. and Lind, C. 1981. Biospecific adsorption of hepatic DT-diaphorase on immobilized dicoumarol: I. Purification of cytosolic DT-diaphorase from control and 3-methylcholanthrene-treated rats. Archives of biochemistry and biophysics 207, 205-216.
DOI
ScienceOn
|
29 |
Jackson, J., Higo, T., Hunter, W. and Burt, H. 2008. Topoisomerase inhibitors as anti-arthritic agents. Inflammation Res 57, 126-134.
DOI
|
30 |
Hartner, L., Rosen, L., Hensley, M., Mendelson, D., Staddon, A., Chow, W., Kovalyov, O., Ruka, W., Skladowski, K. and Jagiello-Gruszfeld, A. 2007. Phase 2 dose multi-center, open-label study of ARQ 501, a checkpoint activator, in adult patients with persistent, recurrent or metastatic leiomyosarcoma (LMS). J Clin Oncol 25, 20521.
|
31 |
Hodnick, W. F., Kalyanaraman, B., Pritsos, C. A. and Pardini, R. S. 1988. The production of hydroxyl and semiquinone free radicals during the autoxidation of redox active flavonoids. Basic Life Sci 49, 149-152.
|
32 |
Huang, L. and Pardee, A. B. 1999. beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells. Mol Med 5, 711-720.
|
33 |
Kawecki, A., Adkins, D., Cunningham, C., Vokes, E., Yagovane, D., Dombal, G., Koralewski, P., Hotko, Y. and Vladimirov, V. 2007. A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck. J Clin Oncol 25, 16509.
|
34 |
Jaiswal, A. K., Burnett, P., Adesnik, M. and McBride, O. W. 1990. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H: quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry 29, 1899-1906.
DOI
ScienceOn
|
35 |
Jaiswal, A. K., McBride, O. W., Adesnik, M. and Nebert, D. W. 1988. Human dioxin-inducible cytosolic NAD(P) H: menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J Biol Chem 263, 13572-13578.
|
36 |
Joseph, P. and Jaiswal, A. K. 1994. NAD(P)H: quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 91, 8413-8417.
DOI
|
37 |
Lai, C. C., Liu, T. J., Ho, L. K., Don, M. J. and Chau, Y. P. 1998. beta-Lapachone induced cell death in human hepatoma (HepA2) cells. Histol Histopathol 13, 89-97.
|
38 |
Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G. and Sartorelli, A. C. 1984. Role of NADPH: cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Cancer Res 44, 5638-5643.
|
39 |
Kumi-Diaka, J. 2002. Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and beta- lapachone. Biol Cell 94, 37-44.
DOI
ScienceOn
|
40 |
Lewis, A. M., Ough, M., Hinkhouse, M. M., Tsao, M. S., Oberley, L. W. and Cullen, J. J. 2005. Targeting NAD(P)H: quinone oxidoreductase (NQO1) in pancreatic cancer. Mol Carcinog 43, 215-224.
DOI
|
41 |
Li, C. J., Li, Y. Z., Pinto, A. V. and Pardee, A. B. 1999. Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints. Proc Natl Acad Sci USA 96, 13369-13374.
DOI
ScienceOn
|
42 |
Li, C. J., Wang, C. and Pardee, A. B. 1995. Induction of apoptosis by beta-lapachone in human prostate cancer cells. Cancer Res 55, 3712-3715.
|
43 |
Li, Y., Li, C. J., Yu, D. and Pardee, A. B. 2000. Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells. Mol Med 6, 1008-1015.
|
44 |
Lind, C., Cadenas, E., Hochstein, P. and Ernster, L. 1990. DT-diaphorase: purification, properties, and function. Methods Enzymol 186, 287-301.
DOI
|
45 |
Long, D. J., 2nd, Waikel, R. L., Wang, X. J., Roop, D. R. and Jaiswal, A. K. 2001. NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[ a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 93, 1166-1170.
DOI
|
46 |
Lind, C., Hochstein, P. and Ernster, L. 1982. DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation. Arch Biochem Biophys 216, 178-185.
DOI
ScienceOn
|
47 |
Liu, T. J., Lin, S. Y. and Chau, Y. P. 2002. Inhibition of poly(ADP-ribose) polymerase activation attenuates beta-lapachone-induced necrotic cell death in human osteosarcoma cells. Toxicol Appl Pharmacol 182, 116-125.
DOI
|
48 |
Menacho-Marquez, M. and Murguia, J. R. 2006. Beta-lapachone activates a Mre11p-Tel1p G1/S checkpoint in budding yeast. Cell Cycle 5, 2509-2516.
DOI
|
49 |
Long, D. J., 2nd, Waikel, R. L., Wang, X. J., Perlaky, L., Roop, D. R. and Jaiswal, A. K. 2000. NAD(P)H: quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a) pyrene-induced mouse skin carcinogenesis. Cancer Res 60, 5913-5915.
|
50 |
Martin, L. F., Patrick, S. D. and Wallin, R. 1987. DT-diaphorase in morbidly obese patients. Cancer Lett 36, 341-347.
DOI
|
51 |
Mikami, K., Naito, M., Tomida, A., Yamada, M., Sirakusa, T. and Tsuruo, T. 1996. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines. Cancer Res 56, 2823-2826.
|
52 |
Nishiyama, T., Izawa, T., Usami, M., Ohnuma, T., Ogura, K. and Hiratsuka, A. 2010. Cooperation of NAD(P)H: quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells. Biochem Biophys Res Commun 394, 459-463.
DOI
|
53 |
Park, H. J., Choi, E. K., Choi, J., Ahn, K. J., Kim, E. J., Ji, I. M., Kook, Y. H., Ahn, S. D., Williams, B., Griffin, R., Boothman, D. A., Lee, C. K. and Song, C. W. 2005. Heat-induced up-regulation of NAD(P)H: quinone oxidoreductase potentiates anticancer effects of beta-lapachone. Clin Cancer Res 11, 8866-8871.
DOI
ScienceOn
|
54 |
Pardee, A. B., Li, Y. Z. and Li, C. J. 2002. Cancer therapy with beta-lapachone. Curr Cancer Drug Targets 2, 227-242.
DOI
ScienceOn
|
55 |
Park, E. J., Choi, K. S. and Kwon, T. K. 2011. beta- Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem Biol Interact 189, 37-44.
DOI
|
56 |
Schaffner-Sabba, K., Schmidt-Ruppin, K. H., Wehrli, W., Schuerch, A. R. and Wasley, J. W. 1984. beta-Lapachone: synthesis of derivatives and activities in tumor models. J Med Chem 27, 990-994.
DOI
|
57 |
Pink, J. J., Planchon, S. M., Tagliarino, C., Varnes, M. E., Siegel, D. and Boothman, D. A. 2000. NAD(P)H: quinone oxidoreductase activity is the principal determinant of beta- lapachone cytotoxicity. J Biol Chem 275, 5416-5424.
DOI
ScienceOn
|
58 |
Prochaska, H. J. and Talalay, P. 1986. Purification and characterization of two isofunctional forms of NAD(P)H: quinone reductase from mouse liver. J Biol Chem 261, 1372-1378.
|
59 |
Radjendirane, V., Joseph, P., Lee, Y. H., Kimura, S., Klein-Szanto, A. J., Gonzalez, F. J. and Jaiswal, A. K. 1998. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 273, 7382-7389.
DOI
ScienceOn
|
60 |
Raftell, M. and Blomberg, K. 1980. Immunochemical studies on two DT diaphorase active antigens isolated from rat liver cytosol by affinity chromatography. Arch Biochem Biophys 199, 165-171.
DOI
|
61 |
Ross, D., Kepa, J. K., Winski, S. L., Beall, H. D., Anwar, A. and Siegel, D. 2000. NAD(P)H: quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem Biol Interact 129, 77-97.
DOI
|
62 |
Ross, D. and Siegel, D. 2004. NAD(P)H: quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol 382, 115-144.
DOI
|
63 |
Segura-Aguilar, J., Kaiser, R. and Lind, C. 1992. Separation and characterization of isoforms of DT-diaphorase from rat liver cytosol. Biochim Biophys Acta 1120, 33-42.
DOI
|
64 |
Ough, M., Lewis, A., Bey, E. A., Gao, J., Ritchie, J. M., Bornmann, W., Boothman, D. A., Oberley, L. W. and Cullen, J. J. 2005. Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1. Cancer Biol Ther 4, 95-102.
DOI
|
65 |
Bey, E. A., Reinicke, K. E., Srougi, M. C., Varnes, M., Anderson, V. E., Pink, J. J., Li, L. S., Patel, M., Cao, L., Moore, Z., Rommel, A., Boatman, M., Lewis, C., Euhus, D. M., Bornmann, W. G., Buchsbaum, D. J., Spitz, D. R., Gao, J. and Boothman, D. A. 2013. Catalase abrogates beta-lapachone- induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers. Mol Cancer Ther 12, 2110-2120.
DOI
|
66 |
Bey, E. A., Bentle, M. S., Reinicke, K. E., Dong, Y., Yang, C. R., Girard, L., Minna, J. D., Bornmann, W. G., Gao, J. and Boothman, D. A. 2007. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA 104, 11832-11837.
DOI
ScienceOn
|
67 |
Gupta, D., Podar, K., Tai, Y. T., Lin, B., Hideshima, T., Akiyama, M., LeBlanc, R., Catley, L., Mitsiades, N., Mitsiades, C., Chauhan, D., Munshi, N. C. and Anderson, K. C. 2002. Beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells. Exp Hematol 30, 711-720.
DOI
|
68 |
Pink, J. J., Wuerzberger-Davis, S., Tagliarino, C., Planchon, S. M., Yang, X., Froelich, C. J. and Boothman, D. A. 2000. Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during beta-lapachone-mediated apoptosis. Exp Cell Res 255, 144-155.
DOI
ScienceOn
|
69 |
Kikuchi, T., Sugiura, Y. and Komiyama, T. 1981. Generation of semiquinone radical from carbazilquinone by NADPHcytochrome P-450 reductase. Biochem Pharmacol 30, 1717-1718.
DOI
|